| Date Filed | Type | Description |
| 11/22/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Financial Statement... |
| 11/20/2019 |
8-K
| Resignation/termination of a director|
Docs:
|
"ARTICLE ONE The name of the corporation is Celgene Corporation . ARTICLE TWO The address of the Corporation’ s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company. ARTICLE THREE The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware. ARTICLE FOUR The total number of shares which the Corporation shall have the authority to issue is One Thousand shares, all of which shall be shares of Common Stock, with a par value of $0.01 per share. ARTICLE FIVE The directors shall have the power to adopt, amend or repeal By...",
"BYLAWS OF",
"ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT",
"CELGENE Announces plans to transfer listing of Celgene’ s Contingent value rights following Closing of Acquisition by Bristol-Myers Squibb" |
|
| 10/31/2019 |
8-K
| Quarterly results |
| 08/26/2019 |
8-K
| Acquisition/merger/asset purchase announced |
| 07/30/2019 |
8-K
| Quarterly results |
| 04/25/2019 |
8-K
| Quarterly results |
| 04/12/2019 |
8-K
| Quarterly results |
| 04/04/2019 |
8-K
| Other Events |
| 03/29/2019 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/26/2019 |
8-K
| Other Events |
| 03/08/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/31/2019 |
8-K
| Quarterly results |
| 01/25/2019 |
8-K/A
| Financial Statements and Exhibits |
| 01/07/2019 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 01/04/2019 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/03/2019 |
8-K
| Investor presentation |
| 11/02/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/25/2018 |
8-K
| Quarterly results |
| 07/26/2018 |
8-K
| Quarterly results |
| 07/09/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/05/2018 |
8-K
| Other Events |
| 06/28/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/19/2018 |
8-K
| Quarterly results |
| 06/13/2018 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 06/01/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/31/2018 |
8-K
| Regulation FD Disclosure |
| 05/24/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 05/18/2018 |
8-K/A
| Financial Statements and Exhibits |
| 05/04/2018 |
8-K
| Quarterly results |
| 04/30/2018 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 04/19/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/02/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/06/2018 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
| 02/27/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
|